1,3-Dioxan-5-ylalkenoic acids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

549373, 549375, A61K 31335, C07D31906

Patent

active

045671974

ABSTRACT:
The invention concerns novel 4-phenyl-1,3-dioxan-5-ylalkenoic acid derivatives of the formula I having cis relative stereochemistry at positions 4 and 5 of the dioxane ring and wherein Ra and Rb are variously hydrogen, alkyl, halogenoalkyl, alkenyl, and optionally substituted aryl or arylalkyl, Rc is hydroxy, alkoxy or alkanesulphonamido, n is 1 or 2, A is ethylene or vinylene, Y is (2-5C)polymethylene optionally substituted by alkyl, and benzene ring B is optionally substituted phenyl, or, when Rc is hydroxy, a salt thereof. The acid derivatives antagonize one or more of the actions of thromboxane A.sub.2 (TXA.sub.2) and are expected to be of value in those disease conditions in which TXA.sub.2 is involved. The invention also provides pharmaceutical compositions containing an acid derivative of formula I, and processes for their chemical production.

REFERENCES:
J. Fried et al. in "Advances in Prostaglandin and Thromboxane Research", vol. 6, pp. 427-436, Raven Press, New York, 1980.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,3-Dioxan-5-ylalkenoic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3-Dioxan-5-ylalkenoic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-Dioxan-5-ylalkenoic acids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1306554

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.